These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 9379065

  • 1. Fas ligand expression and function in systemic lupus erythematosus.
    McNally J, Yoo DH, Drappa J, Chu JL, Yagita H, Friedman SM, Elkon KB.
    J Immunol; 1997 Nov 01; 159(9):4628-36. PubMed ID: 9379065
    [Abstract] [Full Text] [Related]

  • 2. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb 01; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 3. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y.
    Cell Immunol; 2005 Jun 01; 235(2):117-21. PubMed ID: 16226734
    [Abstract] [Full Text] [Related]

  • 4. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
    Feng Y.
    Hokkaido Igaku Zasshi; 1997 Jul 01; 72(4):443-55. PubMed ID: 9266252
    [Abstract] [Full Text] [Related]

  • 5. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF.
    Arthritis Rheum; 2005 Jan 01; 52(1):201-11. PubMed ID: 15641052
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T.
    Arthritis Rheum; 1998 Feb 01; 41(2):344-53. PubMed ID: 9485093
    [Abstract] [Full Text] [Related]

  • 7. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM, Taher TE, Isenberg DA, Mageed RA.
    Scand J Rheumatol; 2009 Feb 01; 38(2):112-20. PubMed ID: 19110660
    [Abstract] [Full Text] [Related]

  • 8. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
    Tsai HF, Lai JJ, Chou AH, Wang TF, Wu CS, Hsu PN.
    Arthritis Rheum; 2004 Feb 01; 50(2):629-39. PubMed ID: 14872508
    [Abstract] [Full Text] [Related]

  • 9. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y, Thoburn CJ, Bright EC, Hess AD.
    Biol Blood Marrow Transplant; 2004 Mar 01; 10(3):156-70. PubMed ID: 14993881
    [Abstract] [Full Text] [Related]

  • 10. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
    Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, Yagita H.
    J Immunol; 1999 Mar 01; 162(5):2639-47. PubMed ID: 10072506
    [Abstract] [Full Text] [Related]

  • 11. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A, Nguyen P, Finkelman F, Elkon KB, Via CS.
    J Immunol; 1998 Sep 15; 161(6):2848-55. PubMed ID: 9743345
    [Abstract] [Full Text] [Related]

  • 12. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S.
    Cell Immunol; 1997 Nov 01; 181(2):182-91. PubMed ID: 9398405
    [Abstract] [Full Text] [Related]

  • 13. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes.
    Sobek V, Balkow S, Körner H, Simon MM.
    Eur J Immunol; 2002 Sep 01; 32(9):2490-9. PubMed ID: 12207333
    [Abstract] [Full Text] [Related]

  • 14. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB.
    Biol Blood Marrow Transplant; 2005 Aug 01; 11(8):576-86. PubMed ID: 16041307
    [Abstract] [Full Text] [Related]

  • 15. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S.
    Cell Immunol; 1997 Nov 25; 182(1):20-8. PubMed ID: 9427806
    [Abstract] [Full Text] [Related]

  • 16. Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells.
    Khanolkar A, Yagita H, Cannon MJ.
    Virology; 2001 Aug 15; 287(1):79-88. PubMed ID: 11504544
    [Abstract] [Full Text] [Related]

  • 17. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
    Li Q, Nakadai A, Takeda K, Kawada T.
    Toxicology; 2004 Nov 01; 204(1):41-50. PubMed ID: 15369847
    [Abstract] [Full Text] [Related]

  • 18. Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactions.
    Bergmann-Leitner ES, Abrams SI.
    Cell Immunol; 2001 Apr 10; 209(1):49-62. PubMed ID: 11414736
    [Abstract] [Full Text] [Related]

  • 19. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q.
    Rheumatology (Oxford); 2005 Oct 10; 44(10):1245-54. PubMed ID: 15987711
    [Abstract] [Full Text] [Related]

  • 20. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
    Lewinsohn DM, Bement TT, Xu J, Lynch DH, Grabstein KH, Reed SG, Alderson MR.
    J Immunol; 1998 Mar 01; 160(5):2374-9. PubMed ID: 9498779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.